Jaap-Jan Roukens

Dr. Jaap-Jan Roukens

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
JRJaap-Jan Roukens
Jaap-Jan Roukens
While recent reviews have firmly established hidradenitis suppurativa (HS) as a systemic inflammatory disorder inextricably linked to metabolic comorbidities, the investigation of lifestyle determinants remains a fraction of the research effort compared to the pursuit of pharmaceuticals. Consequently, current clinical approaches may not fully leverage natural modulators of systemic environmental inflammatory influx, a potential driver of the disease. The central premise of this study posits that the compromise of follicular integrity is directly coupled to lifestyle-driven systemic inflammation exceeding a critical threshold. While previous studies have relied on statistical regression and probabilistic frameworks for HS, this study establishes a deterministic multi-compartment ordinary differential equation framework to simulate the longitudinal kinetics of systemic and local lesion inflammation. Represented in this framework is the first mathematical formalization of the 2025 European S2k guideline interventions, explicitly modeling the resistance kinetics of antibiotics, the immunogenic decay of biologics, and the tapering dynamics of corticosteroids to simulate their longitudinal efficacy in HS. Furthermore, we introduce an abstractified framework that applies the laws of mass balance and pharmacokinetics directly to the disease state and key biologically relevant parameters, rather than focusing on cell types, targets, and individual cytokines. In this HS PK model, the lesion is connected to the systemic inflammation and acts as an integrator and amplifier, recording transient systemic spikes as permanent structural debt through an effect of hysteresis that progressively decouples the lesion from the systemic driver. Simulation studies suggest biologic agents provide a buffering capacity that creates a therapeutic equilibrium, which differs from resolving the underlying inflammatory mass balance. When evaluated across a virtual cohort, this reveals distinct kinetic populations. We demonstrate that clinical rebound is mathematically governed by phase space topology, where the disease state acts as a stable natural equilibrium. Upon pharmaceutical cessation, the therapeutic equilibrium collapses, causing the system to shift rapidly back to the disease state, driven by the underlying inflammatory load. Consequently, a comparative rescue trial demonstrated that pharmacological escalation encounters a saturation ceiling. This suggests that sustainable remission in HS may require a transformation that shifts the equilibrium itself, redefining lifestyle modification from an adjuvant option to the fundamental variable required to treat HS effectively.

12 February 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
JRJaap-Jan Roukens
Jaap-Jan Roukens
The contemporary breeding of Cannabis sativa L. has shifted toward exotic chemovars defined by fruity, floral, and sweet aromas, traits driven by minor volatile esters rather than quantitatively dominant terpenes. Despite their economic importance, the enzymatic machinery governing the synthesis of these high-value volatile esters remains uncharacterized. This study presents a genome-wide identification and tissue-specific expression landscape of the CsBAHD acyltransferase superfamily, the metabolic drivers of ester biosynthesis. Using a custom hidden Markov model (HMM), 108 high-confidence CsBAHD genes were identified in the cs10 reference genome. Physical mapping reveals a non-uniform distribution characterized by dense telomeric gene clusters on chromosomes 1, 2, 4, 5, and 8. While these dynamic regions facilitate rapid chemical diversification via chromosomal recombination, their hyper-variability contributes to linkage drag and the phenotypic instability of exotic traits observed during hybridization. Integration with multi-tissue transcriptomic datasets identified distinct transcripts for the putative enzymes governing ester biosynthesis in the glandular trichome. CsBAHD45 is a constitutively expressed high-abundance transcript (mean: 1953 TPM), whereas chemotypic diversity is generated by a subset of hyper-variable genes, including CsBAHD19 and CsBAHD16, which exhibit extreme presence/absence variation across the plants. It is proposed that this strain-specific repertoire drives the accumulation of high-value odorants, including sulfur-containing esters responsible for tropical passionfruit notes, phenethyl esters driving honey and fruit nuances, and acetylated terpenes analogous to the floral profiles of lavender and rose. Structural validation via physicochemical fingerprinting and deep modeling with the ESM-2 protein language model confirmed a striking topological consensus with functionally reviewed reference enzymes. Beyond the floral sink, distinct vegetative gene clusters were identified that govern root zone defense, stem fiber lignification, and seed coat maturation. Phylotranscriptomic analysis suggests that the aerial floral biosynthetic capacity evolved via the neofunctionalization of these ancestral core-fiber and root-defense genes. Finally, this study proposes a physicochemical sequestration model, hypothesizing that ancestral CsBAHDs catalyzed the formation of cannabinoid esters to stabilize volatile defensive terpenes as persistent contact insecticides. Consequently, the modern high-potency chemotype may be the product of anthropogenic selection, where the selection for free THC drove the loss of this ester-based defence system. Collectively, these findings provide a high-resolution genomic blueprint for the de-orphaning of the CsBAHD superfamily, establishing molecular targets for the marker-assisted breeding of premium aromatic chemovars, optimized industrial fiber properties, and robust root-zone defense systems.

13 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
JRJaap-Jan Roukens
Jaap-Jan Roukens
Pain is a key symptom in hidradenitis suppurativa (HS) and up to one-third of patients use cannabis. Despite this clinical signal, the endocannabinoid system (ECS) and molecular nociceptive networks remain essentially uncharacterized. Transcriptomic comparisons between HS patients and healthy controls were conducted utilizing bulk RNA-seq (blood and skin) alongside cutaneous scRNA-seq. A curated 134-gene panel mapped the peripheral nociceptive network, encompassing neurotrophic and immune signaling, extracellular matrix remodeling, and bioactive lipid mediators. Compared with healthy controls, bulk transcriptomic profiling of HS patients revealed nine ECS-related genes differentially expressed in lesional skin and eight in the blood. Additionally, seven distinct bioactive lipid mediator genes were dysregulated within HS lesions, suggesting a lesion-level shift in prostaglandin, thromboxane, and leukotriene biosynthesis. At single-cell resolution, of the five major cell populations analyzed, keratinocytes and T cells played a relatively minor role in the broader pain signature. In contrast, mononuclear phagocytes (MNPs) and fibroblasts emerged as central cellular amplifiers of peripheral nociception. MNPs significantly dysregulated 48 panel genes, including the biosynthetic machinery for nociceptive lipid mediators across the endocannabinoid, prostaglandin, leukotriene, and thromboxane axes. Moreover, MNPs amplify pain networks by inducing pronociceptive chemokines, cytokines, alarmins, neuropeptides, mechanotransducers, and matrix-remodeling proteases, a shift potentiated by substantial hypoxic and oxidative adaptations. Fibroblasts exhibited a broad transcriptomic shift altering 46 pain-network genes, dysregulating matrix-remodeling, inflammatory, and lipid mediator pathways. Critically, the alteration of neurotrophic factors, plasminogen activators, and axon guidance molecules suggest a permissive environment for disorganized hyperinnervation. Furthermore, the sensory ion channel TRPA1 emerged as a significantly upregulated stromal sensor, with this entire nociceptive signature correlating with CXCL13-positive immunofibroblasts. Additionally, leveraging the high B cell density in HS lesions enabled a novel intratissue trajectory analysis, revealing constitutive lipid mediator expression without significant transcriptomic shifts across memory, plasmablast, and plasma cell maturation stages. Finally, in silico intersection of this pathogenic profile with the druggable proteome identified precision therapeutic candidates, encompassing targetable GPCRs, FDA-approved monoclonal antibodies against inflammatory nodes, and experimental sphingolipid and leukotriene cascade inhibitors. Collectively, this study establishes the first systematic transcriptomic map of the peripheral nociceptive network and endocannabinoidome in hidradenitis suppurativa, providing both a mechanistic framework for disease-associated nociception and a biological rationale for targeted therapeutic intervention.

31 March 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
JRJaap-Jan Roukens
Jaap-Jan Roukens
Hidradenitis suppurativa (HS) is a severe inflammatory dermatosis characterized by profound localized pain. Current pathophysiological models of HS focus primarily on microscopic molecular networks and microbiological dysbiosis. Although the psychosocial and behavioral burdens of the disease are individually well-documented, these factors have not yet been integrated into a single macroscopic feedback model. This self-sustaining system operates across three interacting domains: (1) a biomechanical-metabolic loop, where sustained immobility accelerates the accumulation of visceral adiposity and insulin resistance; (2) a psychosocial-physiological loop, where pain-induced sleep disruption and chronic stress drive neuroendocrine dysregulation and maladaptive coping behaviors; and (3) a socioeconomic loop, where economic instability decreases healthcare security. Consequently, these behavioral, psychological, and socioeconomic burdens feed back into the systemic inflammatory core, perpetuating disease chronicity. Moreover, this review explores kinesiophobia (the anticipatory fear of movement) as a potentially critical and overlooked component of the biomechanical-metabolic feedback loop. Currently, there is a notable absence of primary psychometric data quantifying kinesiophobia in the HS population. Future research should aim to quantify this phenomenon to better establish its prevalence and clinical significance. On a macroscopic level, clinicians should aim to systematically break the broader interconnected behavioral feedback loops through multidisciplinary interventions, including cognitive-behavioral therapy and structured patient education. Ultimately, dismantling these psychological and behavioral barriers may be a critical step to attenuate systemic inflammatory amplification and improve long-term clinical outcomes.